X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (411) 411
Conference Proceeding (29) 29
Patent (28) 28
Book Review (15) 15
Publication (5) 5
Book / eBook (1) 1
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (220) 220
humans (200) 200
male (156) 156
female (151) 151
middle aged (144) 144
oncology (142) 142
aged (135) 135
surgery (134) 134
medicine & public health (101) 101
cancer (95) 95
adult (88) 88
stomach neoplasms - surgery (77) 77
surgical oncology (72) 72
prognosis (65) 65
analysis (64) 64
stomach cancer (58) 58
stomach neoplasms - pathology (55) 55
treatment outcome (55) 55
aged, 80 and over (54) 54
chemotherapy (54) 54
esophageal cancer (54) 54
gastric cancer (54) 54
gastrectomy (52) 52
gastroenterology & hepatology (47) 47
neoplasm staging (46) 46
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
medical colleges (42) 42
retrospective studies (41) 41
survival rate (41) 41
abdominal surgery (36) 36
follow-up studies (36) 36
esophageal neoplasms - pathology (35) 35
esophageal neoplasms - surgery (35) 35
gastrectomy - methods (33) 33
gastroenterology (33) 33
stomach neoplasms - drug therapy (33) 33
survival (29) 29
tumors (28) 28
laparoscopy (26) 26
adenocarcinoma - surgery (25) 25
care and treatment (25) 25
esophageal neoplasms - drug therapy (25) 25
lymphatic metastasis (25) 25
neoadjuvant therapy (25) 25
metastasis (24) 24
trial (24) 24
carcinoma (23) 23
japan (23) 23
adenocarcinoma (22) 22
esophageal neoplasms - mortality (22) 22
disease-free survival (21) 21
medical prognosis (21) 21
squamous cell carcinoma (21) 21
adenocarcinoma - pathology (20) 20
drug combinations (20) 20
prospective studies (20) 20
risk factors (20) 20
thoracic surgery (20) 20
cancer research (19) 19
health aspects (19) 19
laparoscopic surgery (19) 19
mortality (19) 19
recurrence (19) 19
research (19) 19
squamous-cell carcinoma (19) 19
stomach neoplasms - mortality (19) 19
carcinoma, squamous cell - pathology (18) 18
carcinoma, squamous cell - surgery (18) 18
chemoradiotherapy (18) 18
combined modality therapy (18) 18
lymph node excision (18) 18
adjuvant treatment (17) 17
carcinoma, squamous cell - drug therapy (17) 17
cisplatin - administration & dosage (17) 17
esophageal neoplasms - therapy (17) 17
esophagectomy (17) 17
multivariate analysis (17) 17
neoadjuvant chemotherapy (17) 17
oxonic acid - administration & dosage (17) 17
tegafur - administration & dosage (17) 17
young adult (17) 17
carcinoma, squamous cell - mortality (16) 16
s-1 (16) 16
time factors (16) 16
cardiac surgery (15) 15
cisplatin (15) 15
esophageal squamous cell carcinoma (15) 15
esophagus (15) 15
immunohistochemistry (15) 15
laparoscopy - methods (15) 15
oncology, experimental (15) 15
physics (15) 15
stomach (15) 15
adenocarcinoma - mortality (14) 14
cell line, tumor (14) 14
chemotherapy, adjuvant (14) 14
feasibility studies (14) 14
resection (14) 14
vascular surgery (14) 14
abridged index medicus (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 309 - 318
Journal Article
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2013, Volume 20, Issue S3, pp. 607 - 615
There is increasing evidence that microRNA expression in cancer tissue is useful for predicting the prognosis of patients with cancer. However, the... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | TO-MESENCHYMAL TRANSITION | HEPATOCELLULAR-CARCINOMA | PLASMA | ONCOLOGY | PANCREATIC-CANCER | SQUAMOUS-CELL CARCINOMA | RESISTANCE | SERUM | PROLIFERATION | MICRORNAS | EXPRESSION | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Case-Control Studies | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Aged, 80 and over | Esophageal Neoplasms - mortality | Female | Neoadjuvant Therapy | Adenocarcinoma - genetics | Real-Time Polymerase Chain Reaction | Doxorubicin - administration & dosage | RNA, Messenger - genetics | Survival Rate | Reverse Transcriptase Polymerase Chain Reaction | Adenocarcinoma - drug therapy | Biomarkers, Tumor - blood | Taxoids - administration & dosage | Carcinoma, Squamous Cell - drug therapy | Esophageal Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Biomarkers, Tumor - genetics | MicroRNAs - blood | MicroRNAs - genetics | Neoplasm Staging | Esophageal Neoplasms - drug therapy | Adenocarcinoma - mortality | Medical research | MicroRNA | Analysis | Adjuvant treatment | Medicine, Experimental | Esophageal cancer | Cancer | Index Medicus
Journal Article
Cancer Science, ISSN 1347-9032, 02/2018, Volume 109, Issue 2, pp. 412 - 421
TP 53 is associated with the resistance of cytotoxic treatment and patient prognosis, and the mutation rate of TP 53 in esophageal squamous cell carcinoma (... 
esophageal squamous cell carcinoma | 1 | PRIMA | apoptosis | TP | 53 | Noxa | TP53 | PRIMA-1 | MULTIPLE-MYELOMA | CANCER CELLS | INHIBITS GROWTH | DEATH | MECHANISMS | INDUCTION | CHEMOTHERAPY | BREAST-CANCER | ONCOLOGY | REACTIVATION | MUTANT P53 | Up-Regulation | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Aza Compounds - pharmacology | Mutation, Missense | Tumor Suppressor Protein p53 - genetics | Proto-Oncogene Proteins c-bcl-2 - metabolism | Esophageal Neoplasms - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Esophageal Squamous Cell Carcinoma | Cell Survival - drug effects | Aza Compounds - administration & dosage | Tumor Suppressor Protein p53 - metabolism | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Sequence Analysis, DNA | Xenograft Model Antitumor Assays | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Carcinoma, Squamous Cell - drug therapy | Esophageal Neoplasms - genetics | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Esophageal Neoplasms - drug therapy | Apoptosis | Squamous cell carcinoma | Analysis | Genetic aspects | Nucleotide sequencing | Tumor proteins | Esophageal cancer | DNA sequencing | p53 Protein | Multiple myeloma | Recovery of function | Frameshift mutation | Cytotoxicity | Mutation rates | Cancer therapies | Western blotting | Proteins | Cell growth | Missense mutation | Cell cycle | Xenografts | Deoxyribonucleic acid--DNA | Medical research | Breast cancer | Radiation therapy | Esophagus | Chemotherapy | Medical prognosis | Cell lines | Antitumor activity | Mutation | Prostate cancer | Index Medicus | PRIMA‐1 | Original
Journal Article
Gastric Cancer, ISSN 1436-3291, 5/2018, Volume 21, Issue 3, pp. 446 - 452
Journal Article
Cancer, ISSN 0008-543X, 10/2012, Volume 118, Issue 19, pp. 4785 - 4794
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2016, Volume 19, Issue 3, pp. 817 - 826
Journal Article